{
  "abstract": "Although immune checkpoint inhibitors (ICI) have greatly improved outcomes in several cancer types, their use is also associated with immune-related adverse events (irAEs) that can impact any organ system and lead to significant morbidity and even mortality. Current approaches to treatment of irAEs largely rely on the use of systemic corticosteroids, which can compromise antitumor immune responses and oncologic outcomes. Prolonged use of systemic corticosteroids is also associated with its own set of toxicities. Thus, there is a critical need for steroid-sparing treatment approaches for irAEs.In this article, we review the literature for alternative therapeutic approaches for irAEs, which include targeted delivery (alternate routes of administration) of steroids (eg, budesonide) as well as systemic non-steroidal strategies using other mechanisms of action, such as integrin/cytokine blockade, antibody depletion, disease-modifying antirheumatic drugs and fecal microbiota transplant, among others. Many of these approaches have shown significant promise in their ability to induce a clinical response and improve symptoms, even in the setting of steroid-refractory or steroid-dependent irAEs. These approaches are being increasingly used as primary and secondary prophylaxis in patients at high risk of irAEs. Importantly, these strategies may mitigate steroid-associated toxicities, preserve antitumor immune responses and allow continuation of ICI after development of irAEs, hence enabling the full potential of ICI against cancer.",
  "authors": [
    {
      "affiliations": [
        "University of Washington, Seattle, Washington, USA",
        "Fred Hutchinson Cancer Center, Seattle, Washington, USA"
      ],
      "name": "Jennifer J Huang"
    },
    {
      "affiliations": [
        "University of Washington, Seattle, Washington, USA",
        "Fred Hutchinson Cancer Center, Seattle, Washington, USA"
      ],
      "name": "Maryam YousefiAsl"
    },
    {
      "affiliations": [
        "University of Washington, Seattle, Washington, USA"
      ],
      "name": "Namrata Singh"
    },
    {
      "affiliations": [
        "University of Washington, Seattle, Washington, USA",
        "Fred Hutchinson Cancer Center, Seattle, Washington, USA"
      ],
      "name": "Petros Grivas"
    },
    {
      "affiliations": [
        "University of Washington, Seattle, Washington, USA",
        "Fred Hutchinson Cancer Center, Seattle, Washington, USA"
      ],
      "name": "Shailender Bhatia"
    }
  ],
  "title": "Steroid-sparing strategies for managing immune-related adverse events",
  "uid": "42e00e5a-c1f6-5e02-aee2-7717e9a478b3"
}